Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection

The 2019–2020 winter was marked by the emergence of a new coronavirus (SARS-CoV-2) related disease (COVID-19), which started in Wuhan, China. Its high human-to-human transmission ability led to a worldwide spread within few weeks and has caused substantial human loss. Mechanical antiviral control ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kombe Kombe, Arnaud John, Zahid, Ayesha, Mohammed, Ahmed, Shi, Ronghua, Jin, Tengchuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201996/
https://www.ncbi.nlm.nih.gov/pubmed/34136533
http://dx.doi.org/10.3389/fmolb.2021.670815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201996/
https://www.ncbi.nlm.nih.gov/pubmed/34136533
http://dx.doi.org/10.3389/fmolb.2021.670815

Ejemplares similares